Is epilepsy a preventable disorder? New evidence from animal models.
Epilepsy accounts for 0.5% of the global burden of disease, and primary prevention of epilepsy represents one of the three 2007 NINDS Epilepsy Research Benchmarks. In the past decade, efforts to understand and intervene in the process of epileptogenesis have yielded fruitful preventative strategies in animal models.This article reviews the current understanding of epileptogenesis, introduces the concept of a "critical period" for epileptogenesis, and examines strategies for epilepsy prevention in animal models of both acquired and genetic epilepsies. We discuss specific animal models, which may yield important insights into epilepsy prevention including kindling, poststatus epilepticus, prolonged febrile seizures, traumatic brain injury, hypoxia, the tuberous sclerosis mouse model, and the WAG/Rij rat model of primary generalized epilepsy. Hopefully, further investigation of antiepileptogenesis in animal models will soon enable human therapeutic trials to be initiated, leading to long-term epilepsy prevention and improved patient quality of life.
Giblin
Kathryn A
KA
Department of Neurology, Yale University School of Medicine, New Haven, CT 06520-8018, USA.
Blumenfeld
Hal
H
D000818:Animals; D004195:Disease Models, Animal; D004827:Epilepsy / Q000209:etiology / Q000235:genetics / Q000503:physiopathology* / Q000517:prevention & control*; D019317:Evidence-Based Medicine / Q000379:methods / Q000639:trends; D020022:Genetic Predisposition to Disease; D006801:Humans; D009431:Neural Conduction / Q000235:genetics / Q000502:physiology